A bill for an act relating to manufacturers and distributors of 340B drugs.

Summary

The bill defines “340B drug,” “manufacturer,” and “distributor,” then bars manufacturers or distributors from denying or restricting a covered entity’s acquisition of a 340B drug or its delivery to a contract pharmacy, unless the U.S. Department of Health and Human Services expressly prohibits it. It is intended to safeguard the ability of safety‑net providers to obtain discounted medicines. The measure is currently referred to a Senate subcommittee.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share